[Evaluation of the effectiveness of the drug Cytoflavin in patients with dyscirculatory encephalopathy who have undergone a new coronavirus infection].

L A Belova V V Mashin D R Dolgova A A Kuvayskaya L R Kruglova S S Sukhikh T D Plaksina

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)

Cytoflavin therapy at a dosage of 2 tablets 2 times a day for 25 days can be recommended as part of complex therapy for patients with DE and a COVID-19.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
randomized controlled trial
systematic review
early onset
adverse drug
stem cells
emergency department
drug induced
electronic health record